​
​

LumiraDx (LMDX) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

LMDX Stock Forecast

LumiraDx stock forecast is as follows: an average price target of $1.50 (represents a 9900.00% upside from LMDX’s last price of $0.01) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

LMDX Price Target

The average price target for LumiraDx (LMDX) is $1.50 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $1.50 to $1.50. This represents a potential 9900.00% upside from LMDX's last price of $0.01.

LMDX Analyst Ratings

Buy

According to 1 Wall Street analysts, LumiraDx's rating consensus is 'Buy'. The analyst rating breakdown for LMDX stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

LumiraDx Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 07, 2023Andrew CooperRaymond James$1.50$0.62141.16%9900.00%
Row per page
Go to

The latest LumiraDx stock forecast, released on Apr 07, 2023 by Andrew Cooper from Raymond James, set a price target of $1.50, which represents a 141.16% increase from the stock price at the time of the forecast ($0.62), and a 9900.00% increase from LMDX last price ($0.01).

LumiraDx Price Target by Period

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.01$0.01$0.01
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of LumiraDx stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to LumiraDx's last price of $0.01. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Apr 07, 2023Raymond JamesOutperformOutperformHold
May 12, 2022Raymond JamesOutperformOutperformHold
Row per page
Go to

LumiraDx's last stock rating was published by Raymond James on Apr 07, 2023. The company gave LMDX a "Outperform" rating, the same as its previous rate.

LumiraDx Financial Forecast

LumiraDx Revenue Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Mar 22
Revenue------$22.17M$126.41M
Avg Forecast$47.26M$42.01M$36.76M$31.15M$20.53M$21.00M$41.75M$113.13M
High Forecast$49.05M$43.60M$38.15M$31.15M$20.53M$21.80M$43.33M$117.41M
Low Forecast$45.73M$40.65M$35.57M$31.15M$20.53M$20.33M$40.40M$109.47M
# Analysts1112211-
Surprise %------0.53%1.12%

LumiraDx's average Quarter revenue forecast for Jun 23 based on 1 analysts is $21.00M, with a low forecast of $20.33M, and a high forecast of $21.80M. LMDX's average Quarter revenue forecast represents a -5.27% decrease compared to the company's last Quarter revenue of $22.17M (Mar 23).

LumiraDx EBITDA Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Mar 22
# Analysts1112211-
EBITDA------$-20.84M$-17.62M
Avg Forecast$-32.40M$-28.80M$-25.20M$-21.36M$-14.08M$-14.40M$-28.63M$-77.57M
High Forecast$-33.63M$-29.89M$-26.16M$-21.36M$-14.08M$-14.95M$-29.71M$-80.50M
Low Forecast$-31.36M$-27.87M$-24.39M$-21.36M$-14.08M$-13.94M$-27.70M$-75.06M
Surprise %------0.73%0.23%

undefined analysts predict LMDX's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than LumiraDx's previous annual EBITDA (undefined) of $NaN.

LumiraDx Net Income Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Mar 22
# Analysts1112211-
Net Income------$-44.12M$-56.17M
Avg Forecast$490.24M$426.77M$501.12M$-19.13M$-35.08M$-47.83M$-60.59M$-19.13M
High Forecast$392.19M$341.42M$400.89M$-19.13M$-35.08M$-38.27M$-48.47M$-15.31M
Low Forecast$588.28M$512.13M$601.34M$-19.13M$-35.08M$-57.40M$-72.70M$-22.96M
Surprise %------0.73%2.94%

LumiraDx's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. LMDX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

LumiraDx SG&A Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Mar 22
# Analysts1112211-
SG&A------$25.98M$40.16M
Avg Forecast$26.10M$23.20M$20.30M$17.20M$11.34M$11.60M$23.06M$62.48M
High Forecast$27.09M$24.08M$21.07M$17.20M$11.34M$12.04M$23.93M$64.84M
Low Forecast$25.26M$22.45M$19.64M$17.20M$11.34M$11.23M$22.31M$60.46M
Surprise %------1.13%0.64%

LumiraDx's average Quarter SG&A projection for Jun 23 is $11.60M, based on 1 Wall Street analysts, with a range of $11.23M to $12.04M. The forecast indicates a -55.34% fall compared to LMDX last annual SG&A of $25.98M (Mar 23).

LumiraDx EPS Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Mar 22
# Analysts1112211-
EPS------$-0.14$-0.22
Avg Forecast$1.54$1.34$1.57$-0.06$-0.11$-0.15$-0.19$-0.06
High Forecast$1.23$1.07$1.26$-0.06$-0.11$-0.12$-0.15$-0.05
Low Forecast$1.84$1.61$1.89$-0.06$-0.11$-0.18$-0.23$-0.07
Surprise %------0.74%3.67%

According to undefined Wall Street analysts, LumiraDx's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to LMDX previous annual EPS of $NaN (undefined).

LumiraDx Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
LMDXLumiraDx$0.02$1.507400.00%Buy
DRIODarioHealth$0.80$10.751243.75%Buy
GTHGenetron$4.03$10.00148.14%-
BDSXBiodesix$1.26$3.00138.10%Buy
XGNExagen$3.00$5.0066.67%Buy
SHCSotera Health Company$13.88$17.4325.58%Buy
OLKOlink AB (publ)$26.08$21.50-17.56%Hold

LMDX Forecast FAQ

Is LumiraDx a good buy?

Yes, according to 1 Wall Street analysts, LumiraDx (LMDX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of LMDX's total ratings.

What is LMDX's price target?

LumiraDx (LMDX) average price target is $1.5 with a range of $1.5 to $1.5, implying a 9900.00% from its last price of $0.015. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will LumiraDx stock go up soon?

According to Wall Street analysts' prediction for LMDX stock, the company can go up by 9900.00% (from the last price of $0.015 to the average price target of $1.5), up by 9900.00% based on the highest stock price target, and up by 9900.00% based on the lowest stock price target.

Can LumiraDx stock reach $0?

LMDX's average twelve months analyst stock price target of $1.5 supports the claim that LumiraDx can reach $0 in the near future.

What are LumiraDx's analysts' financial forecasts?

LMDX's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $114.43M (high $116.81M, low $112.41M), average EBITDA is $-78.462M (high $-80.089M, low $-77.072M), average net income is $-163M (high $-141M, low $-184M), average SG&A $63.2M (high $64.51M, low $62.08M), and average EPS is $-0.51 (high $-0.442, low $-0.578).

Did the LMDX's actual financial results beat the analysts' financial forecasts?

In terms of the last quarterly report (Mar 2023), LumiraDx's revenue was $22.17M, missing the average analysts' forecast of $41.75M by -46.89%. The company's EBITDA was $-20.837M, missing the average prediction of $-28.626M by -27.21%. LumiraDx's net income was $-44.123M, missing the average estimation of $-60.587M by -27.17%. The company's SG&A was $25.98M, beating the average forecast of $23.06M by 12.66%. Lastly, the company's EPS was $-0.14, missing the average prediction of $-0.19 by -26.32%